AlphaYouRS
Insider selling
Robin Shane Readnour sold $213K of AN2 Therapeutics, Inc. (ANTX) stock
Robin Shane Readnour, Dir of AN2 Therapeutics, Inc. (ANTX), sold 35,402 shares of ANTX stock worth $213K, per an SEC Form 4 filed Aug 19, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 17, 2026, 2 days before it was made public.
ANTX has moved -13.4% since the trade date, from $5.73 to $4.96 (Sep 21, 2026 close).
- Traded
- Aug 17, 2026
- Disclosed
- Aug 19, 2026
- Filing delay
- 2 days
- Price since
- -13.4%
- Role
- Dir
- Source
- SEC Form 4
More ANTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.